Role of m6A Reader YTHDC2 in Differentiation of Human Bone Marrow Mesenchymal Stem Cells

WEN Jun-ru, TAN Zhen, LIN Wei-min, LI Qi-wen, YUAN Quan

Abstract

To study the regulatory effect of YTH domain-containing protein 2 (YTHDC2), a member of N6-methyladenosine (m6A) readers, on the osteogenic or adipogenic differentiation of human bone marrow mesenchymal stem cells (hBMSCs).  Methods  YTHDC2 expression was knocked down by small interfering RNA (siRNA) in vitro. Osteogenic differentiation and adipogenic differentiation of hBMSCs were induced after YTHDC2 knockdown in order to study the changes in the differentiation phenotype of hBMSCs. Alkaline phosphatase staining (ALP staining) and alizarin red S staining were performed to examine osteogenic activity and calcium-nodular formation. Nile red staining was performed to examine lipid-droplet formation. Real-time quantitative polymerase chain reaction (RT-qPCR) was used to assess the expression of osteogenesis and adipogenesis-related genes. RNA-sequencing was performed to identify the transcriptome changes after YTHDC2 knockdown and to explore the potential regulatory mechanism by which YTHDC2 regulated the diferentiation of hBMSCs.  Results  In this study, we found that siRNA-induced YTHDC2 knockdown resulted in increased ALP activity and calcium-nodular formation of hBMSCs during osteogenic differentiation, and significantly upregulated the expression of osteogenesis-related genes. In addition, the lipid-droplet formation capacity of hBMSCs was decreased during adipogenic differentiation. The expression of adipogenesis-related genes was significantly down-regulated. Gene-set enrichmen analysis of RNA-seq data showed that YTHDC2 was significantly correlated with ribosome function and mRNA-translation-related signaling pathways.  Conclusion  The findings indicate that YTHDC2 knockdown can promote the osteogenic differentiation of hBMSCs and inhibit the adipogenic differentiation. YTHDC2 knockdown may cause changes in ribosome function.

 

Keywords: YTH domain-containing protein 2, Human bone marrow mesenchymal stem cells, N6-methyladenosine, Osteogenic differentiation, Adipogenic differentiation

 

Full Text:

PDF


References


FENG Q， ZHENG S， ZHENG J. The emerging role of microRNAs in bone remodeling and its therapeutic implications for osteoporosis. Biosci Rep， 2018， 38(3): BSR20180453[2021-04-14]. https://doi.org/10. 1042/BSR20180453.

GARIA-GARCIA A， DE CASTILLEJO C L， MENDEZ-FERRER S. BMSCs and hematopoiesis. Immunol Lett，2015，168(2): 129–135.

CICCIU M， BRAMANTI E， CECCHETTI F， et al. FEM and Von Mises analyses of different dental implant shapes for masticatory loading distribution. Oral Implantol (Rome)，2014，7(1): 1–10.

KOUZARIDES T. Chromatin modifications and their function. Cell， 2007，128(4): 693–705.

MACHNICKA M A， MILANOWSKA K， OSMAN OGL O U， et al. MODOMICS: a database of RNA modification pathways—2013 update. Nucleic Acids Res， 2013， 41:D262-D267[2021-04-14]. https://doi.org/10. 1093/nar/gks1007.

ZHANG C， FU J， ZHOU Y. A review in research progress concerning m6A methylation and immunoregulation. Front Immunol， 2019， 10: 922[2021-04-14]. https://doi.org/10.3389/fimmu.2019.00922.

FU Y， DOMINISSINI D， RECHAVI G， et al. Gene expression regulation mediated through reversible m6A RNA methylation. Nat Rev Genet，2014，15(5): 293–306.

WU H， ZHANG Y. Reversing DNA methylation: mechanisms, genomics, and biological functions. Cell，2014，156(1/2): 45–68.

WU Y， XIE L， WANG M， et al. Mettl3-mediated m6A RNA methylation regulates the fate of bone marrow mesenchymal stem cells and osteoporosis. Nat Commun， 2018， 9(1): 4772[2021-04-14]. https://doi. org/10.1038/s41467-018-06898-4.

YAO Y， BI Z， WU R， et al. METTL3 inhibits BMSC adipogenic differentiation by targeting the JAK1/STAT5/C/EBPβ pathway via an m6A-YTHDF2-dependent manner. FASEB J，2019，33(6): 7529–7544.

HSU P J， ZHU Y， MA H， et al. YTHDC2 is an N6-methyladenosine binding protein that regulates mammalian spermatogenesis. Cell Res， 2017，27(9): 1115–1127.

SOH Y Q S， MIKEDIS M M， KOJIMA M， et al. Meioc maintains an extended meiotic prophase I in mice. PLoS Genet， 2017， 13(4): e1006704[2021-04-14]. https://doi.org/10.1371/journal.pgen.1006704.

BAILEY A S， BATISTA P J， GOLD R S， et al. The conserved RNA helicase YTHDC2 regulates the transition from proliferation to differentiation in the germline. eLife， 2017， 6: e26116[2021-04-14]. https://doi.org/10.7554/eLife.26116.

JAIN D， PUNO M R， MEYDAN C， et al. ketu mutant mice uncover an essential meiotic function for the ancient RNA helicase YTHDC2. elife， 2018， 7: e30919[2021-04-14]. https://doi.org/ 10.7554/eLife.30919.

FANALE D， IOVANNA J L， CALVO E L， et al. Germline copy number variation in the YTHDC2 gene: does it have a role in finding a novel potential molecular target involved in pancreatic adenocarcinoma susceptibility? Expert Opin Ther Targets，2014，18(8): 841–850.

XU D， SHAO J， SONG H， et al. The YTH domain family of N6-methyladenosine “readers” in the diagnosis and prognosis of colonic adenocarcinoma. Biomed Res Int， 2020，2020:9502560[2021-04-14]. https://doi.org/10.1155/2020/9502560.

TANABE A， TANIKAWA K， TSUNETOMI M， et al. RNA helicase YTHDC2 promotes cancer metastasis via the enhancement of the efficiency by which HIF-1α mRNA is translated. Cancer Lett，2016， 376(1): 34–42.

SUN S， HAN Q， LIANG M， et al. Downregulation of m6 A reader YTHDC2 promotes tumor progression and predicts poor prognosis in non-small cell lung cancer. Thorac Cancer，2020，11(11): 3269–3279.

MA L， CHEN T， ZHANG X， et al. The m6A reader YTHDC2 inhibits lung adenocarcinoma tumorigenesis by suppressing SLC7A11-dependent antioxidant function. Redox Biol， 2021， 38:101801[2021-04-14]. https://doi.org/10.1016/j.redox.2020.101801.

LI Y， ZHENG J N， WANG E H， et al. The m6A reader protein YTHDC2 is a potential biomarker and associated with immune infiltration in head and neck squamous cell carcinoma. Peer J， 2020， 8: e10385[2021-04-14]. https://doi.org/10.7717/peerj.10385.

VIMALRAJ S. Alkaline phosphatase: structure， expression and its function in bone mineralization. Gene， 2020， 754: 144855[2021-04-14]. https://doi.org/10.1016/j.gene.2020.144855.

NAGY A， GERTSENSTEIN M， VINTERSTEN K， et al. Alizarin red staining of post-natal bone in mouse. Cold Spring Harb Protoc， 2009， 2009(3): pdb.prot5171[2021-04-14].https://doi.org/10.1101/pdb.prot5171.

CHEN X， HUA W， HUANG X， et al. Regulatory role of RNA N6-methyladenosine modification in bone biology and osteoporosis. Front Endocrinol (Lausanne)， 2020，1(10):911[2021-04-14]. https://doi.org/ 10.3389/fendo.2019.00911.


Refbacks

  • There are currently no refbacks.